Pfizer CEO: It'll be 2020 before issues in sterile injectables manufacturing are resolved

It appears it will be another hard year for U.S. hospitals to get their hands on sterile injectables as work continues at Pfizer’s troubled plant in Kansas, perhaps the largest U.S. producer of the drugs.